26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

838

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

June 30, 2009

Conditions
Hypertension
Interventions
DRUG

fixed-dose combination of telmisartan 40mg+amlodipine 10mg

DRUG

fixed-dose combination of telmisartan 80mg+amlodipine10mg

Trial Locations (92)

Unknown

1235.8.61003 Boehringer Ingelheim Investigational Site, Gosford

1235.8.61004 Boehringer Ingelheim Investigational Site, Liverpool

1235.8.61002 Boehringer Ingelheim Investigational Site, Kippa-Ring

1235.8.61001 Boehringer Ingelheim Investigational Site, Milton

1235.8.61005 Boehringer Ingelheim Investigational Site, Elizabeth Vale

1235.8.43007 Boehringer Ingelheim Investigational Site, Eggenburg

1235.8.43006 Boehringer Ingelheim Investigational Site, Hainburg A.d. Donau

1235.8.43001 Boehringer Ingelheim Investigational Site, Vienna

1235.8.43002 Boehringer Ingelheim Investigational Site, Vienna

1235.8.43003 Boehringer Ingelheim Investigational Site, Vienna

1235.8.35912 Boehringer Ingelheim Investigational Site, Burgas

1235.8.35902 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35903 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35904 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35905 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35906 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35907 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35910 Boehringer Ingelheim Investigational Site, Sofia

1235.8.35911 Boehringer Ingelheim Investigational Site, Sofia

1235.8.42002 Boehringer Ingelheim Investigational Site, Benátky nad Jizerou

1235.8.42006 Boehringer Ingelheim Investigational Site, Brno

1235.8.42001 Boehringer Ingelheim Investigational Site, Pilsen

1235.8.42003 Boehringer Ingelheim Investigational Site, Prague

1235.8.42004 Boehringer Ingelheim Investigational Site, Příbram

1235.8.42005 Boehringer Ingelheim Investigational Site, Slaný

1235.8.42007 Boehringer Ingelheim Investigational Site, Strakonice

1235.8.35304 Boehringer Ingelheim Investigational Site, Birr

1235.8.35305 Boehringer Ingelheim Investigational Site, Carrigtowhill

1235.8.35303 Boehringer Ingelheim Investigational Site, Gorey, Co. Wexford

1235.8.35306 Boehringer Ingelheim Investigational Site, Mallow

1235.8.35301 Boehringer Ingelheim Investigational Site, New Ross

1235.8.39002 Boehringer Ingelheim Investigational Site, Broni (pv)

1235.8.39006 Boehringer Ingelheim Investigational Site, Coppito (AQ)

1235.8.39001 Boehringer Ingelheim Investigational Site, Ferrara

1235.8.64003 Boehringer Ingelheim Investigational Site, Dunedin

1235.8.64002 Boehringer Ingelheim Investigational Site, Otahuhu, Auckland

1235.8.64001 Boehringer Ingelheim Investigational Site, Tauranga

1235.8.70004 Boehringer Ingelheim Investigational Site, Moscow

1235.8.70005 Boehringer Ingelheim Investigational Site, Moscow

1235.8.70006 Boehringer Ingelheim Investigational Site, Moscow

1235.8.70007 Boehringer Ingelheim Investigational Site, Moscow

1235.8.70008 Boehringer Ingelheim Investigational Site, Moscow

1235.8.70009 Boehringer Ingelheim Investigational Site, Moscow

1235.8.70010 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.8.70011 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.8.70012 Boehringer Ingelheim Investigational Site, Saint Petersburg

1235.8.42103 Boehringer Ingelheim Investigational Site, Dolný Kubín

1235.8.42106 Boehringer Ingelheim Investigational Site, Kralovsky Chmlec

1235.8.42104 Boehringer Ingelheim Investigational Site, Liptovský Mikuláš

1235.8.42102 Boehringer Ingelheim Investigational Site, Považská Bystrica

1235.8.42105 Boehringer Ingelheim Investigational Site, Prešov

1235.8.42101 Boehringer Ingelheim Investigational Site, Trenčín

1235.8.42107 Boehringer Ingelheim Investigational Site, Vráble

1235.8.34008 Boehringer Ingelheim Investigational Site, Badalona

1235.8.34010 Boehringer Ingelheim Investigational Site, Badalona

1235.8.34009 Boehringer Ingelheim Investigational Site, Barcelona

1235.8.34001 Boehringer Ingelheim Investigational Site, Jerez de La Frontera (Cádiz)

1235.8.34006 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat (Barcelona)

1235.8.34003 Boehringer Ingelheim Investigational Site, Madrid

1235.8.34004 Boehringer Ingelheim Investigational Site, Madrid

1235.8.34012 Boehringer Ingelheim Investigational Site, Mataró

1235.8.34002 Boehringer Ingelheim Investigational Site, Oviedo

1235.8.34005 Boehringer Ingelheim Investigational Site, Santa Coloma de Gramanet

1235.8.34011 Boehringer Ingelheim Investigational Site, Santa Coloma de Gramanet

1235.8.38010 Boehringer Ingelheim Investigational Site, Dnipro

1235.8.38001 Boehringer Ingelheim Investigational Site, Kharkiv

1235.8.38003 Boehringer Ingelheim Investigational Site, Kharkiv

1235.8.38008 Boehringer Ingelheim Investigational Site, Kharkiv

1235.8.38011 Boehringer Ingelheim Investigational Site, Kharkiv

1235.8.38004 Boehringer Ingelheim Investigational Site, Kiev

1235.8.38006 Boehringer Ingelheim Investigational Site, Kiev

1235.8.38012 Boehringer Ingelheim Investigational Site, Kiev

1235.8.38013 Boehringer Ingelheim Investigational Site, Kiev

1235.8.38002 Boehringer Ingelheim Investigational Site, Lviv

1235.8.38005 Boehringer Ingelheim Investigational Site, Odesa

1235.8.38009 Boehringer Ingelheim Investigational Site, Odesa

1235.8.38007 Boehringer Ingelheim Investigational Site, Zaporizhzhya

1235.8.44010 Boehringer Ingelheim Investigational Site, Bexhill-on-Sea

1235.8.44008 Boehringer Ingelheim Investigational Site, Blackpool

1235.8.44016 Boehringer Ingelheim Investigational Site, Blackpool

1235.8.44011 Boehringer Ingelheim Investigational Site, Burbage

1235.8.44007 Boehringer Ingelheim Investigational Site, Chestfield, Whitstable

1235.8.44005 Boehringer Ingelheim Investigational Site, Chorley

1235.8.44002 Boehringer Ingelheim Investigational Site, Edgbaston, Birmingham

1235.8.44009 Boehringer Ingelheim Investigational Site, Ely

1235.8.44001 Boehringer Ingelheim Investigational Site, Fowey

1235.8.44003 Boehringer Ingelheim Investigational Site, Glasgow

1235.8.44012 Boehringer Ingelheim Investigational Site, Penzance

1235.8.44013 Boehringer Ingelheim Investigational Site, Plymouth

1235.8.44004 Boehringer Ingelheim Investigational Site, Reading

1235.8.44015 Boehringer Ingelheim Investigational Site, St Austell

1235.8.44006 Boehringer Ingelheim Investigational Site, Whitstable

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00624052 - 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension | Biotech Hunter | Biotech Hunter